This provider's $4.8M in total Medicare payments ranks in the 99th percentile of Gynecological Oncology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 52% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $455.48 | $118.56 | 3.84x | $336.92 | $394.2K | 9.0K | 2.5K |
| 2015 | $398.88 | $104.27 | 3.83x | $294.61 | $359.4K | 9.0K | 2.8K |
| 2016 | $472.50 | $127.41 | 3.71x | $345.09 | $544.9K | 8.9K | 3.0K |
| 2017 | $468.94 | $135.53 | 3.46x | $333.41 | $588.2K | 8.2K | 3.0K |
| 2018 | $431.43 | $127.12 | 3.39x | $304.31 | $771.1K | 10.9K | 3.4K |
| 2019 | $415.55 | $136.69 | 3.04x | $278.86 | $682.1K | 10.1K | 3.1K |
| 2020 | $457.41 | $133.24 | 3.43x | $324.17 | $618.9K | 10.0K | 2.9K |
| 2021 | $488.43 | $117.30 | 4.16x | $371.13 | $412.2K | 9.3K | 2.8K |
| 2022 | $323.13 | $67.51 | 4.79x | $255.62 | $235.7K | 8.3K | 2.8K |
| 2023 | $289.80 | $61.37 | 4.72x | $228.43 | $235.0K | 9.0K | 2.9K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 805 | $2.5M | $3.1K | 2.36x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 3.5K | $340.4K | $98.52 | 3.55x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 6.8K | $338.3K | $49.90 | 1.82x |
| 74177 | CT scan of abdomen and pelvis with contrast | 1.4K | $226.1K | $159.33 | 12.21x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 2.5K | $199.7K | $79.48 | 1.59x |
| 86304 | Immunologic analysis for detection of tumor antigen | 5.3K | $124.7K | $23.75 | 3.28x |
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 158 | $109.3K | $691.48 | 4.66x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 716 | $107.3K | $149.88 | 2.21x |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 125 | $87.7K | $701.71 | 3.44x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 9.0K | $78.1K | $8.69 | 4.03x |
| 80048 | Blood test, basic group of blood chemicals | 8.7K | $76.1K | $8.78 | 6.49x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 1.4K | $67.4K | $48.03 | 2.91x |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 3.0K | $67.1K | $22.28 | 10.32x |
| Q2050 | Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10mg | 222 | $64.5K | $290.68 | 2.84x |
| 71260 | CT scan chest with contrast | 1.2K | $58.6K | $50.50 | 14.04x |
| 80076 | Liver function blood test panel | 6.1K | $46.1K | $7.56 | 5.29x |
| 96361 | Hydration infusion into a vein | 4.0K | $40.6K | $10.07 | 17.87x |
| 36415 | Insertion of needle into vein for collection of blood sample | 10.4K | $36.7K | $3.54 | 2.82x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 164 | $32.3K | $196.73 | 2.80x |
| 96415 | Infusion of chemotherapy into a vein | 1.4K | $30.5K | $21.51 | 13.02x |
This provider submits charges 3.73 times higher than what Medicare actually pays.
A markup ratio of 3.73x means for every $100 Medicare pays, this provider initially charges $373. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data